THERAPY WITH CELLS FROM HUMAN PLACENTA AND HEMATOPOIETIC CELLS

To provide methods for reducing the severity or duration of graft versus host disease, and for treating or ameliorating symptoms of metabolic disorders and hematologic diseases, such as hematologic malignancies.SOLUTION: A method of transplanting human umbilical cord blood (UCB) cells to a subject c...

Full description

Saved in:
Bibliographic Details
Main Authors ROBERT J HARIRI, ZHANG XIAOKUI, JODI P GURNEY, STACY HERB
Format Patent
LanguageEnglish
Japanese
Published 07.11.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To provide methods for reducing the severity or duration of graft versus host disease, and for treating or ameliorating symptoms of metabolic disorders and hematologic diseases, such as hematologic malignancies.SOLUTION: A method of transplanting human umbilical cord blood (UCB) cells to a subject comprises administering UCB cells in combination with a population of mononuclear cells from human placental perfusate, where the UCB cells are not related to the subject.SELECTED DRAWING: None 【課題】移植片対宿主病の重症度または持続期間を減少させ、代謝異常や血液悪性腫瘍などの血液学的疾患の症状を治療または寛解するための方法の提供。【解決手段】ヒト臍帯血(UCB)細胞を対象に移植する方法であって、ヒト胎盤灌流液由来の単核球の集団と組み合わせてUCB細胞を投与することを含み、前記UCB細胞は、前記対象と非血縁である、方法。【選択図】なし
AbstractList To provide methods for reducing the severity or duration of graft versus host disease, and for treating or ameliorating symptoms of metabolic disorders and hematologic diseases, such as hematologic malignancies.SOLUTION: A method of transplanting human umbilical cord blood (UCB) cells to a subject comprises administering UCB cells in combination with a population of mononuclear cells from human placental perfusate, where the UCB cells are not related to the subject.SELECTED DRAWING: None 【課題】移植片対宿主病の重症度または持続期間を減少させ、代謝異常や血液悪性腫瘍などの血液学的疾患の症状を治療または寛解するための方法の提供。【解決手段】ヒト臍帯血(UCB)細胞を対象に移植する方法であって、ヒト胎盤灌流液由来の単核球の集団と組み合わせてUCB細胞を投与することを含み、前記UCB細胞は、前記対象と非血縁である、方法。【選択図】なし
Author STACY HERB
ZHANG XIAOKUI
JODI P GURNEY
ROBERT J HARIRI
Author_xml – fullname: ROBERT J HARIRI
– fullname: ZHANG XIAOKUI
– fullname: JODI P GURNEY
– fullname: STACY HERB
BookMark eNrjYmDJy89L5WSwC_FwDXIMiFQI9wzxUHB29fEJVnAL8vdV8Aj1dfRTCPBxdHb1C3FUcPRzUfBw9XUM8Q_w93QN8XSGqOVhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhpaGliZGhoaOxkQpAgCu-Cwl
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ヒト胎盤および造血細胞由来の細胞による治療
ExternalDocumentID JP2019194211A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2019194211A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:12:44 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2019194211A3
Notes Application Number: JP20190112450
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191107&DB=EPODOC&CC=JP&NR=2019194211A
ParticipantIDs epo_espacenet_JP2019194211A
PublicationCentury 2000
PublicationDate 20191107
PublicationDateYYYYMMDD 2019-11-07
PublicationDate_xml – month: 11
  year: 2019
  text: 20191107
  day: 07
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies ANTHROGENESIS CORP
RelatedCompanies_xml – name: ANTHROGENESIS CORP
Score 3.3593361
Snippet To provide methods for reducing the severity or duration of graft versus host disease, and for treating or ameliorating symptoms of metabolic disorders and...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title THERAPY WITH CELLS FROM HUMAN PLACENTA AND HEMATOPOIETIC CELLS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191107&DB=EPODOC&locale=&CC=JP&NR=2019194211A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUaOipjGGt0XGvtwDmtJ1GYRtDRbFJ0IHS9QEiMz473sboDzx1us1l_aS6_XX9u4A7nTDVulYmdqDlbiaOU5tTdl2XUuSpJEqXXf0NA9ODiM76JudgTUowec6FqbIE_pTJEdEi0rQ3rNiv57_X2J5xd_Kxb16x67Zky-bXm2FjhF85EVUvVaTi9iLWY2xZkfUot6S55oId-gO7Obn6DzRPn9p5WEp802f4h_BnkBx0-wYSh-jChywdem1CuyHqxdvbK6Mb3ECjzLgPSreyGtbBoTxbveZ-L04JEE_pBERXcp4JCmhkUcCHlIZi7jNZZstx57Crc8lCzScyPBv2cOO2Ji0cQbl6Ww6OQcyQh-sJiq1LYXgzkHI4xpIGU4ddW41zAuobhF0uZVbhcOcKoLtnCsoZ1_fk2v0upm6KbT1Cz34f8Y
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaPiR2MMb4uOfckDmtJ12XBfwaL4ROhgiZoAkRn_fW8DlCfe2l5zaS-5Xn5tf3cAN6pmynQkdeXeSJqKPkpNRZrmnZIkSSOVqmqpaU5ODkLT7emdvtEvweeKC1PkCf0pkiOiRyXo71lxXs_-L7Hs4m_l_Fa-49D00REtu75Exwg-8iKqdrvF48iOWJ2xVieuh92FrKkj3KFbsG0hJswT7fOXdk5Lma3HFGcfdmJUN8kOoPQxrEKFrUqvVWE3WL54Y3PpfPNDeBAu79L4jbx6wiWM-_4zcbpRQNxeQEMS-5TxUFBCQ5u4PKAiiiOPC48t5h7BtcMFcxVcyOBv24NOvLZo7RjKk-lkfAJkiDFYjmVqGhLBnYWQp6lhT7Pu0OZGQz-F2gZFZxulV1BxReAPfC98qsFeLimId9Y5lLOv7_EFRuBMXhaW-wVde4Kx
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=THERAPY+WITH+CELLS+FROM+HUMAN+PLACENTA+AND+HEMATOPOIETIC+CELLS&rft.inventor=ROBERT+J+HARIRI&rft.inventor=ZHANG+XIAOKUI&rft.inventor=JODI+P+GURNEY&rft.inventor=STACY+HERB&rft.date=2019-11-07&rft.externalDBID=A&rft.externalDocID=JP2019194211A